DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 199 filers reported holding DENALI THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,172,400 | -42.7% | 154,000 | -18.1% | 1.07% | -36.6% |
| Q2 2023 | $5,538,480 | +177.7% | 188,000 | +117.2% | 1.69% | +202.7% |
| Q1 2023 | $1,994,688 | +88.9% | 86,575 | +127.8% | 0.56% | +70.9% |
| Q4 2022 | $1,056,020 | -9.4% | 38,000 | 0.0% | 0.33% | -12.8% |
| Q3 2022 | $1,166,000 | -96.9% | 38,000 | +3298.9% | 0.37% | -5.6% |
| Q2 2022 | $38,000,000 | +363.9% | 1,118 | -97.1% | 0.40% | -78.6% |
| Q1 2022 | $8,192,000 | +607.4% | 38,000 | +46.2% | 1.85% | +615.9% |
| Q4 2021 | $1,158,000 | – | 26,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $298,165,000 | 48.02% |
| Bratton Capital Management, L.P. | 953,035 | $14,600,000 | 28.53% |
| Flagship Pioneering Inc. | 8,005,747 | $122,648,000 | 6.71% |
| Casdin Capital, LLC | 650,000 | $9,958,000,000 | 1.03% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $67,568,000 | 0.50% |
| MARK ASSET MANAGEMENT LP | 68,864 | $1,055,000 | 0.26% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 22,507 | $345,000 | 0.26% |
| Artal Group S.A. | 400,000 | $6,128,000 | 0.25% |
| PIER 88 INVESTMENT PARTNERS LLC | 40,610 | $622,000 | 0.24% |
| HAMILTON LANE ADVISORS LLC | 30,948 | $474,000 | 0.20% |